Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Award
Class A Common Stock
2024-10-01+2,026→ 7,100,454 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.